99 related articles for article (PubMed ID: 18977247)
1. NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy.
Korenova M; Zilka N; Stozicka Z; Bugos O; Vanicky I; Novak M
J Neurosci Methods; 2009 Feb; 177(1):108-14. PubMed ID: 18977247
[TBL] [Abstract][Full Text] [Related]
2. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
3. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
[TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenic rats.
Hrnkova M; Zilka N; Minichova Z; Koson P; Novak M
Brain Res; 2007 Jan; 1130(1):206-13. PubMed ID: 17169350
[TBL] [Abstract][Full Text] [Related]
5. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
Zilka N; Korenova M; Novak M
Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
[TBL] [Abstract][Full Text] [Related]
6. Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy.
Zilka N; Stozicka Z; Kovac A; Pilipcinec E; Bugos O; Novak M
J Neuroimmunol; 2009 Apr; 209(1-2):16-25. PubMed ID: 19232747
[TBL] [Abstract][Full Text] [Related]
7. Neurobehavioral tests in rat models of degenerative brain diseases.
Urbach YK; Bode FJ; Nguyen HP; Riess O; von Hörsten S
Methods Mol Biol; 2010; 597():333-56. PubMed ID: 20013245
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel transgenic rat carrying human tau with mutation P301L.
Korhonen P; van Groen T; Thornell A; Kyrylenko S; Soininen ML; Ojala J; Peltomaa E; Tanila H; Salminen A; Mandelkow EM; Soininen H
Neurobiol Aging; 2011 Dec; 32(12):2314-5. PubMed ID: 20097445
[TBL] [Abstract][Full Text] [Related]
9. A comparative study on pathological features of transgenic rat lines expressing either three or four repeat misfolded tau.
Valachova B; Brezovakova V; Bugos O; Jadhav S; Smolek T; Novak P; Zilka N
J Comp Neurol; 2018 Aug; 526(11):1777-1789. PubMed ID: 29633258
[TBL] [Abstract][Full Text] [Related]
10. Rat tau proteome consists of six tau isoforms: implication for animal models of human tauopathies.
Hanes J; Zilka N; Bartkova M; Caletkova M; Dobrota D; Novak M
J Neurochem; 2009 Mar; 108(5):1167-76. PubMed ID: 19141083
[TBL] [Abstract][Full Text] [Related]
11. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice.
Crawley JN; Paylor R
Horm Behav; 1997 Jun; 31(3):197-211. PubMed ID: 9213134
[TBL] [Abstract][Full Text] [Related]
12. Quantitative T2 mapping as a potential marker for the initial assessment of the severity of damage after traumatic brain injury in rat.
Kharatishvili I; Sierra A; Immonen RJ; Gröhn OH; Pitkänen A
Exp Neurol; 2009 May; 217(1):154-64. PubMed ID: 19416663
[TBL] [Abstract][Full Text] [Related]
13. Systematic, standardized and comprehensive neurological phenotyping of inbred mice strains in the German Mouse Clinic.
Schneider I; Tirsch WS; Faus-Kessler T; Becker L; Kling E; Busse RL; Bender A; Feddersen B; Tritschler J; Fuchs H; Gailus-Durner V; Englmeier KH; de Angelis MH; Klopstock T
J Neurosci Methods; 2006 Oct; 157(1):82-90. PubMed ID: 16720049
[TBL] [Abstract][Full Text] [Related]
14. NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model.
Shiryaev N; Jouroukhin Y; Giladi E; Polyzoidou E; Grigoriadis NC; Rosenmann H; Gozes I
Neurobiol Dis; 2009 May; 34(2):381-8. PubMed ID: 19264130
[TBL] [Abstract][Full Text] [Related]
15. Behavioral impairments of the aging rat.
Altun M; Bergman E; Edström E; Johnson H; Ulfhake B
Physiol Behav; 2007 Dec; 92(5):911-23. PubMed ID: 17675121
[TBL] [Abstract][Full Text] [Related]
16. Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies.
Leem YH; Lim HJ; Shim SB; Cho JY; Kim BS; Han PL
J Neurosci Res; 2009 Aug; 87(11):2561-70. PubMed ID: 19360903
[TBL] [Abstract][Full Text] [Related]
17. Role of caspase-3 in tau truncation at D421 is restricted in transgenic mouse models for tauopathies.
Zhang Q; Zhang X; Chen J; Miao Y; Sun A
J Neurochem; 2009 Apr; 109(2):476-84. PubMed ID: 19200347
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional characteristic of a model for deep-seated lacunar infarct in rats.
Janowski M; Gornicka-Pawlak E; Kozlowska H; Domanska-Janik K; Gielecki J; Lukomska B
J Neurol Sci; 2008 Oct; 273(1-2):40-8. PubMed ID: 18657834
[TBL] [Abstract][Full Text] [Related]
19. Behavioural phenotyping of transgenic mice.
Brown RE
Can J Exp Psychol; 2007 Dec; 61(4):328-44. PubMed ID: 18266509
[TBL] [Abstract][Full Text] [Related]
20. The functional observational battery in adult and developing rats.
Moser VC
Neurotoxicology; 2000 Dec; 21(6):989-96. PubMed ID: 11233768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
